Independent study: Nightingale Health’s blood test shown to enhance health check-ups by predicting many diseases at once
Press release, 7 October 2022 at 9:00 a.m. (EEST) Ground-breaking research on over 100,000 people demonstrates that Nightingale Health Plc’s (“Nightingale Health”) blood test can identify early risk signs for many common diseases all at once in a cost-effective manner. The unique snapshot of a person’s health state captured by Nightingale Health’s proprietary metabolomic blood test was able to improve current health screening tools for several costly diseases, such as heart failure, dementia, and diabetes. The study was conducted